Figures from the RNS presentation suggests an arbitrage opportunity.
1. After EMR has funded the Okvau definitive feasibility study(DFS) and the exploration programme (total cost of approx. A$14m), both EMR and RNS will have approx. $4m each in free cash.
2. EMR has a market cap. of $58.8m (at current price of 4.5c) and RNS has a market cap. of $29.3m (at current price of 5.1c).
3. Based on points 1 & 2, EMR has an enterprise value of $54.8m and RNS has an enterprise value of $25.3m
4. At the completion of the DFS, EMR’s share of the Okvau resource will be 561k ozs of gold(51%) and RNS’s share will be 539k ozs(49%).
5. Based on points 3 & 4, EMR is valued at A$98/resource oz and RNS a$47/resource oz.
6. Based on point 5 and with EMR at 4.5c/share, RNS should be trading at 10.6c/share.
7. A high quality exploration programme has just started which has the capacity of adding substantially to the resource base. Initial results should be available in approx. 6 weeks.
8. The existing resource base is very good quality and deserves a higher valuation/oz than is currently the case.
- Forums
- ASX - By Stock
- RNS
- RNS/EMR Arbitrage.
RNS/EMR Arbitrage.
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online